BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Holubekova V, Kolkova Z, Grendar M, Brany D, Dvorska D, Stastny I, Jagelkova M, Zelinova K, Samec M, Liskova A, Laucekova Z, Kudela E, Bobrovska M, Kalman M, Zubor P, Dankova Z. Pathway Analysis of Selected Circulating miRNAs in Plasma of Breast Cancer Patients: A Preliminary Study. Int J Mol Sci 2020;21:E7288. [PMID: 33023154 DOI: 10.3390/ijms21197288] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Liu X, Papukashvili D, Wang Z, Liu Y, Chen X, Li J, Li Z, Hu L, Li Z, Rcheulishvili N, Lu X, Ma J. Potential utility of miRNAs for liquid biopsy in breast cancer. Front Oncol 2022;12:940314. [DOI: 10.3389/fonc.2022.940314] [Reference Citation Analysis]
2 Eshkoor SA, Ghodsian N, Akhtari-zavare M. MicroRNAs influence and longevity. Egypt J Med Hum Genet 2022;23. [DOI: 10.1186/s43042-022-00316-7] [Reference Citation Analysis]
3 Wijesinghe KM, Kanak MA, Harrell JC, Dhakal S. Single-Molecule Sensor for High-Confidence Detection of miRNA. ACS Sens 2022;7:1086-94. [PMID: 35312280 DOI: 10.1021/acssensors.1c02748] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Richard V, Davey MG, Annuk H, Miller N, Kerin MJ. The double agents in liquid biopsy: promoter and informant biomarkers of early metastases in breast cancer. Mol Cancer 2022;21. [DOI: 10.1186/s12943-022-01506-y] [Reference Citation Analysis]
5 Jia YZ, Liu J, Wang GQ, Song ZF. miR-484: A Potential Biomarker in Health and Disease. Front Oncol 2022;12:830420. [PMID: 35356223 DOI: 10.3389/fonc.2022.830420] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Di Agostino S, Vahabi M, Turco C, Fontemaggi G. Secreted Non-Coding RNAs: Functional Impact on the Tumor Microenvironment and Clinical Relevance in Triple-Negative Breast Cancer. ncRNA 2022;8:5. [DOI: 10.3390/ncrna8010005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
7 Modi A, Purohit P, Gadwal A, Ukey S, Roy D, Fernandes S, Banerjee M. In-Silico Analysis of Differentially Expressed Genes and Their Regulating microRNA Involved in Lymph Node Metastasis in Invasive Breast Carcinoma. Cancer Invest 2021;:1-18. [PMID: 34396887 DOI: 10.1080/07357907.2021.1969574] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Adam-Artigues A, Garrido-Cano I, Carbonell-Asins JA, Lameirinhas A, Simón S, Ortega-Morillo B, Martínez MT, Hernando C, Constâncio V, Burgues O, Bermejo B, Henrique R, Lluch A, Jerónimo C, Eroles P, Cejalvo JM. Identification of a Two-MicroRNA Signature in Plasma as a Novel Biomarker for Very Early Diagnosis of Breast Cancer. Cancers (Basel) 2021;13:2848. [PMID: 34200463 DOI: 10.3390/cancers13112848] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
9 Qattan A, Al-Tweigeri T, Alkhayal W, Suleman K, Tulbah A, Amer S. Clinical Identification of Dysregulated Circulating microRNAs and Their Implication in Drug Response in Triple Negative Breast Cancer (TNBC) by Target Gene Network and Meta-Analysis. Genes (Basel) 2021;12:549. [PMID: 33918859 DOI: 10.3390/genes12040549] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]